Up to 4 million women with irregular periods should be investigated for polyendocrine metabolic ovarian syndrome, according to new NHS guidance.
PMOS, previously known as polycystic ovarian syndrome, is believed to affect up to 13% of reproductive age women, the World Health Organization estimates.
Symptoms include irregular, very short, long or absent periods, excess levels of testosterone, and ovaries with multiple small follicles.
The condition is associated with greater risk of developing type 2 diabetes, cardiovascular disease, sleep apnoea, fatty liver disease, mental health issues and complications in pregnancy.
Source: Guardian, 1 July 2026
0 Comments
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now